This article provides an update on the monthly moving averages we track for the S&P 500 and the Ivy Portfolio after the close of the last business day of the month. The Ivy Portfolio The Ivy Portfolio is based on the asset allocation strategy used by endowment funds from Harvard and Yale. ...

Core Insights - The article provides an update on the monthly moving averages for the S&P 500 and the Ivy Portfolio, which is based on the asset allocation strategy of prestigious endowment funds from Harvard and Yale [1] Group 1 - The S&P 500 moving averages are tracked to assess market trends and performance [1] - The Ivy Portfolio serves as a benchmark for investment strategies, reflecting the asset allocation used by elite endowment funds [1]

Core Insights - Progyny is a leader in fertility benefits, providing comprehensive, outcomes-based solutions that enhance treatment success and manage costs, distinguishing itself in a rapidly expanding healthcare niche [2] - The stock has significantly outperformed competitors with a 90% return over the last year, indicating strong market confidence in its future earnings potential [3] Revenue Growth - Progyny achieved an impressive revenue growth of 11.41% over the last twelve months (LTM), which is higher than most competitors, reflecting strong demand for its fertility benefits [2] - Despite this growth, GMED shows superior growth rates compared to Progyny [2] Profitability Metrics - Progyny's free cash flow margins stand at 15.25% LTM, showcasing competitive performance [2] - The operating margin for Progyny is 6.77% LTM, which is lower than larger competitors like Stryker (19.6%), indicating a less profitable service model compared to device sales [2] - The operating margin of Progyny is slightly higher at 6.8%, but still lags behind its peers [3] Valuation - Progyny's price-to-earnings (P/E) ratio is 40.78, which is considered moderate to high, suggesting limited upside potential if growth slows down [2] - The stock has realized a gain of 94.8%, indicating strong market expectations for its future performance [3]